Access and Awareness of Morbidity Management and Disability Prevention for Lower Limb Lymphatic Filariasis in Post-Mass Drug Administration Districts in Southern India.

IF 1.6 4区医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

American Journal of Tropical Medicine and Hygiene Pub Date : 2025-08-05 Print Date: 2025-10-01 DOI:10.4269/ajtmh.25-0180

Anjali Jog, Arpitha Anbu Deborah, Rohan Michael Ramesh, Kumudha Aruldas, Yuvaraj Baskaran, Judd L Walson, Suma Krishnasastry, Sitara Swarna Rao Ajjampur

{"title":"Access and Awareness of Morbidity Management and Disability Prevention for Lower Limb Lymphatic Filariasis in Post-Mass Drug Administration Districts in Southern India.","authors":"Anjali Jog, Arpitha Anbu Deborah, Rohan Michael Ramesh, Kumudha Aruldas, Yuvaraj Baskaran, Judd L Walson, Suma Krishnasastry, Sitara Swarna Rao Ajjampur","doi":"10.4269/ajtmh.25-0180","DOIUrl":null,"url":null,"abstract":"<p><p>The Global Program to Eliminate Lymphatic Filariasis (LF) aims to eliminate transmission through mass drug administration (MDA) and manage LF disease through morbidity management and disability prevention (MMDP). In this study, surveys on awareness and access to MMDP and quality of life (QoL) among lower limb LF cases in a censused population in two post-MDA districts in Tamil Nadu were conducted. The prevalence of lower limb LF was 0.11% (165/147,871), with 57.6% in reversible stage 1 and 2 categories, 36.4% in stage 3, and 6.1% in stage 4 and above. Among them, 22.4% reported health worker visits, 11.5% were aware of MMDP camps, and 36.4% received MMDP kits. The life activity (mean score: 48.5; SD: 27.3) and mobility (41.2; 24.2) domains exhibited the poorest QoL scores. In post-MDA districts, strengthening the reach and awareness of MMDP programs in communities, especially for early, reversible stages, is pivotal to halting disease progression and improving QoL.</p>","PeriodicalId":7752,"journal":{"name":"American Journal of Tropical Medicine and Hygiene","volume":" ","pages":"839-843"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12493119/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Tropical Medicine and Hygiene","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4269/ajtmh.25-0180","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/1 0:00:00","PubModel":"Print","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

The Global Program to Eliminate Lymphatic Filariasis (LF) aims to eliminate transmission through mass drug administration (MDA) and manage LF disease through morbidity management and disability prevention (MMDP). In this study, surveys on awareness and access to MMDP and quality of life (QoL) among lower limb LF cases in a censused population in two post-MDA districts in Tamil Nadu were conducted. The prevalence of lower limb LF was 0.11% (165/147,871), with 57.6% in reversible stage 1 and 2 categories, 36.4% in stage 3, and 6.1% in stage 4 and above. Among them, 22.4% reported health worker visits, 11.5% were aware of MMDP camps, and 36.4% received MMDP kits. The life activity (mean score: 48.5; SD: 27.3) and mobility (41.2; 24.2) domains exhibited the poorest QoL scores. In post-MDA districts, strengthening the reach and awareness of MMDP programs in communities, especially for early, reversible stages, is pivotal to halting disease progression and improving QoL.

查看原文本刊更多论文

印度南部大规模药物管理区下肢淋巴丝虫病发病率管理和残疾预防的可及性和意识

全球消除淋巴丝虫病规划（LF）旨在通过大规模给药（MDA）消除传播，并通过发病率管理和残疾预防（MMDP）管理淋巴丝虫病。在本研究中，对泰米尔纳德邦两个mda后地区的普查人群中下肢LF病例的认知和获得MMDP和生活质量（QoL）进行了调查。下肢LF患病率为0.11%(165/147,871)，其中可逆1、2期57.6%，3期36.4%，4期及以上6.1%。其中，22.4%报告了卫生工作者访问，11.5%知道MMDP营地，36.4%收到MMDP工具包。生命活动度(平均得分：48.5；SD: 27.3)和流动性(41.2；24.2)个域的QoL评分最低。在mda后地区，加强社区MMDP规划的覆盖面和认识，特别是针对早期可逆阶段，对于阻止疾病进展和改善生活质量至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Tropical Medicine and Hygiene 医学-公共卫生、环境卫生与职业卫生

CiteScore

6.20

自引率

3.00%

发文量

508

审稿时长

3 months

期刊介绍： The American Journal of Tropical Medicine and Hygiene, established in 1921, is published monthly by the American Society of Tropical Medicine and Hygiene. It is among the top-ranked tropical medicine journals in the world publishing original scientific articles and the latest science covering new research with an emphasis on population, clinical and laboratory science and the application of technology in the fields of tropical medicine, parasitology, immunology, infectious diseases, epidemiology, basic and molecular biology, virology and international medicine. The Journal publishes unsolicited peer-reviewed manuscripts, review articles, short reports, images in Clinical Tropical Medicine, case studies, reports on the efficacy of new drugs and methods of treatment, prevention and control methodologies,new testing methods and equipment, book reports and Letters to the Editor. Topics range from applied epidemiology in such relevant areas as AIDS to the molecular biology of vaccine development. The Journal is of interest to epidemiologists, parasitologists, virologists, clinicians, entomologists and public health officials who are concerned with health issues of the tropics, developing nations and emerging infectious diseases. Major granting institutions including philanthropic and governmental institutions active in the public health field, and medical and scientific libraries throughout the world purchase the Journal. Two or more supplements to the Journal on topics of special interest are published annually. These supplements represent comprehensive and multidisciplinary discussions of issues of concern to tropical disease specialists and health issues of developing countries